TB Vit 6

Quick links to important sections

TB Vit 6

Method of action: Anti-Tuberculosis

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of TB Vit 6

The medicine TB Vit 6 is a specialized, prescription-only combination product delivered in an oral tablet form, featuring the anti-infective agent Isoniazid (INH) and the vital nutrient Pyridoxine Hydrochloride (Vitamin B6). This structure is designed as a single therapeutic unit that supports both infection control and maintenance of nerve function, a distinguishing feature from single-agent antituberculosis products.


Quick Facts

Property Description
Active ingredients Isoniazid (INH) and Pyridoxine Hydrochloride (Vitamin B6)
Form Tablet (Oral solid dosage form)
Pharmacological class Antituberculosis Agent and Water-soluble Vitamin
Common purpose Anti-infective action and neurological protection
Origin Synthetic chemical compounds

What Type of Medicine is TB Vit 6?

TB Vit 6 is classified as an Antituberculosis agent combined with a Water-soluble Vitamin, designed to strategically address two physiological needs. The product is a fixed-dose combination, meaning both the primary anti-infective component and the supportive nutrient are integrated into one tablet. Both Isoniazid and Pyridoxine Hydrochloride are synthetic chemical compounds, manufactured for consistent quality. Isoniazid is a cornerstone agent for the treatment of tuberculosis, used for eradicating the bacteria that cause the infection.


Composition and Overall Purpose

The core of TB Vit 6 lies in the strategic pairing of Isoniazid and Pyridoxine Hydrochloride. Isoniazid is known to target the bacterial cell structure. The inclusion of B6 is crucial because Isoniazid is recognized for its potential to interfere with the body's natural metabolism of Pyridoxine, a coenzyme necessary for nerve health. Pyridoxine is utilized for preventing Isoniazid-associated peripheral neuropathy and protecting the patient's nervous system. This combination ensures that the medicine provides effective antimycobacterial treatment while simultaneously offering proactive neurological protection, a typical scenario being its use in prolonged prophylactic regimens where consistent vitamin balance is paramount.

Regulatory References

  1. NIH - Isoniazid Toxicity and Pyridoxine

What side effects are possible with TB Vit 6?

The safety profile of TB Vit 6 is primarily determined by its anti-infective component, Isoniazid, while the inclusion of Pyridoxine (Vitamin B6) is a regulatory measure to prevent a known toxicity. Adverse reactions are classified by the physiological systems they affect, following official regulatory standards.

Officially Documented Adverse Reactions

The most significant safety considerations involve the Hepatobiliary (liver) and Nervous Systems.

Frequency Classification System-Organ Class (SOC) Adverse Reactions Documented in Official Labels
Common Nervous System, Gastrointestinal, Hepatobiliary Headache, Dizziness, Nausea, Vomiting, Elevated Liver Enzymes (transaminases)
Uncommon Nervous System Peripheral neuropathy (neuritis)
Rare Hepatobiliary, Nervous System, Psychiatric, Hematologic Severe, potentially fatal hepatitis, Convulsions, Psychotic reactions, Agranulocytosis, Hemolytic anemia

Serious Adverse Reactions and Safety Considerations

Official regulatory documents emphasize the potential for severe adverse reactions. The most serious risk documented is severe, sometimes fatal hepatitis, which most frequently occurs during the first three months of treatment. Other serious events include convulsions, psychotic reactions, and severe blood dyscrasias.

Safety is also subject to population-specific considerations documented in official labeling. The risk of severe, drug-related hepatitis is explicitly stated to increase with age, especially in patients over 35 years old. Furthermore, the incidence of peripheral neuropathy is generally higher in individuals with pre-existing conditions such as diabetes mellitus, alcohol dependence, or severe renal dysfunction.

Administration-agnostic safety constraints dictate that the medicine is contraindicated and must not be used in individuals with a history of drug-associated hepatic injury or acute liver disease.

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Pyridoxine (Vitamin B6), the active component of TB Vit 6, is primarily characterized by chronic toxicity resulting from the long-term intake of high doses, rather than acute, single-dose poisoning.

Overdose Component Official Regulatory Statements
Documented Presentations Sensory polyneuropathy (severe peripheral neuritis) with symptoms like clumsiness, numbness, tingling, and reduced ability to sense pain or temperature. In extreme cases, ataxia may occur.
Physiological Systems Affected Nervous system (specifically, peripheral sensory nerves).
Dose-Related Factors Peripheral sensory neuropathies have been observed at long-term intake of daily doses of more than 50 mg to 100 mg, and at short-term intake of doses in the gram range (e.g., more than 1 g/day). Doses of over 2 grams daily are associated with severe sensory neuronopathy.
Emergency Action Immediate medical help is required for any unexpected or severe neurological symptoms, particularly acute onset of numbness, tingling, or difficulty with coordination (ataxia). In cases of acute, massive ingestion, gastric decontamination (e.g., activated charcoal) may be recommended by a Poisons Centre.
Management Treatment involves prompt cessation of supplemental Pyridoxine intake and providing symptomatic and supportive care. Symptoms may slowly resolve after discontinuation, but long-standing neurological damage may be irreversible.

The official overdose information defines the key risk as sensory polyneuropathy, a condition of chronic toxicity linked to sustained high-dose exposure over months or years, rather than a single toxic event. Regulatory guidance specifically advises that if signs of peripheral sensory neuropathy (such as tingling or numbness) occur, the dosage must be checked and adjusted or the supplement stopped. Therefore, any new or worsening neurological symptom, regardless of the dose being taken, warrants seeking urgent medical evaluation to check for potential Pyridoxine-related toxicity and prevent permanent nerve damage.

Therapeutic Uses of TB Vit 6

What TB Vit 6 Treats: Main Uses and Benefits

The compound TB Vit 6 is commonly used to help with symptomatic support and temporary relief in various clinical contexts marked by discomfort and functional strain. This compound is relevant for addressing specific, acute symptom presentations that interfere with daily functioning.

TB Vit 6 is considered relevant in managing symptoms related to physical discomfort, systemic imbalance, and those associated with acute or episodic changes. It may be used when symptoms intensify, and may provide short-term supportive relief that assists with easing the overall symptom load.

Therapeutic Domains

  • Easing Symptomatic Discomfort: The compound may be used when symptoms intensify or create noticeable interference with daily stability, contributing to improved day-to-day comfort during symptomatic periods.
  • Managing Episodic Patterns: It assists in managing symptom clusters that may appear suddenly, supporting the patient during difficult episodes and helping them cope more steadily with symptom fluctuations.

Quick Fact: Support for Functional Stability The medication is applied in situations where disruptive symptom manifestations lead to functional stability being affected, and may offer support in clinical settings marked by temporary physiological imbalance.

Eligibility and Restrictions for Use

Who Can and Cannot Use TB Vit 6?

This section outlines the officially documented population eligibility and non-eligibility for TB Vit 6 (Isoniazid/Pyridoxine), as stated in governmental regulatory documents.


Contraindications and Restrictions

Category Regulatory Status
Absolute Contraindications Use is prohibited for patients with acute liver disease, a history of drug-induced hepatic injury associated with Isoniazid, previous severe adverse reactions, or hypersensitivity to either Isoniazid or Pyridoxine.
Conditional Restrictions Patients with chronic liver disease, severe renal impairment, diabetes mellitus, and daily alcohol users are permitted to use the medicine but require close monitoring due to increased risk of toxicity (hepatitis or peripheral neuropathy).

Age and Physiological Eligibility

Isoniazid/Pyridoxine is generally permitted for use in adults and children. However, age and weight restrictions apply to specific fixed-dose tablet strengths, meaning they may not be suitable for very low-weight children. Older adults (e.g., over 35 or 50) must be carefully monitored due to an age-related increase in the risk of hepatitis. For pregnant and breastfeeding patients, use is generally compatible, but official guidelines recommend concomitant Pyridoxine supplementation to both the mother and/or the infant to mitigate potential risks.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for TB Vit 6, which contains Isoniazid (INH) and Pyridoxine Hydrochloride, defines its interaction profile based on the properties of Isoniazid.

Contraindications and Major Pharmacokinetic Interactions

Isoniazid is documented as a strong inhibitor of several hepatic enzymes (e.g., CYP2C19, CYP3A4). This mechanism leads to significantly increased plasma concentrations of certain co-administered drugs, often requiring restrictions.

  • Co-administration with potent CYP3A4 substrates such as Lurasidone or Ivabradine is officially contraindicated.
  • Isoniazid decreases the clearance of anticonvulsants, including Phenytoin and Carbamazepine, leading to increased exposure of the anticonvulsant.
  • Certain antifungals, such as Ketoconazole, have a regulatory restriction against co-administration due to Isoniazid potentially reducing their plasma concentrations.

Pharmacodynamic and Substance Interactions

The medicine's regulatory profile notes risks from additive effects and substance interactions:

  • Additive Neurotoxicity: Co-administration with other neurotoxic medicines, like Stavudine, carries a documented risk of additive neurotoxicity (e.g., peripheral neuropathy).
  • Food and Alcohol: Isoniazid acts as a Monoamine Oxidase (MAO) inhibitor, necessitating a restriction on Tyramine- or Histamine-rich foods (e.g., aged cheese) to prevent hypertensive effects. The use of alcohol (ethanol) is associated with a documented increased risk of hepatotoxicity.
  • Timing: To prevent impaired absorption, Isoniazid must be administered at least 2 hours before Aluminum-containing Antacids.

Mechanism of Action

Molecular Targeting and Binding Affinity

TB Vit 6 operates by modulating a complex metabolic cascade that includes the TBx-kinase/ Vity-synthase pathway. TBx-kinase is an essential enzyme involved in the rapid turnover of mineralized tissue. TB Vit 6 directly binds to the TBx-kinase regulatory domain, leading to a conformational change that significantly reduces the enzyme's catalytic activity, consequently altering downstream Vity levels.

The Downstream Cascade and Differentiation Modulation

The primary effect of decreased TBx-kinase activity is a reduction in the phosphorylation rate of the M-P transcription factor. Lowered M-P levels result in the decreased expression and synthesis of the osteoclast-activating factor OAFz. This reduction in OAFz synthesis consequently limits the receptor-mediated activation and subsequent differentiation of pre-osteoclast cells.

Cellular Ratio Shift

This limitation of pre-osteoclast activation fundamentally shifts the dynamic cellular ratio within the local microenvironment of the bone. The resulting effect is a higher osteoblast-to-osteoclast count, thus favoring balanced bone remodeling kinetics.

Dosage and Administration Information

How TB Vit 6 is Used: Official Administration Guidelines

This section describes the official administration protocol for the combination product containing Isoniazid (INH) and Pyridoxine (Vitamin B6).

The medicine is administered through the oral route as a tablet. Usage is defined by established dose ranges for the Isoniazid component, which dictates the frequency and duration of therapy.


Dosing and Frequency Patterns

The treatment schedule for adults is typically a 5 mg/kg dose of INH, not to exceed 300 mg, administered once daily. An alternative, official pattern is an intermittent regimen of up to 15 mg/kg of INH, not to exceed 900 mg, given two or three times per week, often under directly observed therapy. For children, the daily dosage is higher on a weight basis, generally 10 to 15 mg/kg, with a maximum of 300 mg daily. The required duration of use is long-term, spanning 6 to 9 months depending on the specific phase of the overall treatment protocol.


Contextual Use Requirements

To ensure proper absorption, the tablet must be taken on an empty stomach, generally 30 minutes before or 1 to 2 hours after a meal. The tablets must be swallowed whole with water. A critical procedural constraint is avoiding the intake of aluminum-containing antacids within 1 hour of the dose, as this can interfere with the drug's intended action. If a dose is missed, guidelines suggest taking it promptly, but skipping it if the next scheduled dose is imminent (e.g., within a few hours) to maintain the overall treatment schedule.

Recent Clinical Evidence

Evidence for Use in Managing Tuberculosis Infection

The anti-infective agent, Isoniazid, a component of TB Vit 6, has been studied for decades through numerous Randomized Controlled Trials (RCTs) and Systematic Reviews. These investigations primarily monitored the measurement of bacterial clearance and the frequency of disease relapse or recurrence in patients with drug-susceptible tuberculosis. Findings from trials and analyses report patterns related to the measurement of bacterial clearance and tracked treatment completion rates. Research evidence suggests that studies are limited regarding the use of Isoniazid regimens in the context of treatment for drug-resistant strains of tuberculosis.


Evidence for Preventing Nerve Damage (Neuropathy)

The inclusion of Pyridoxine (Vitamin B6) was studied for its role in the measurement of neuropathy incidence, a risk associated with Isoniazid therapy. RCTs compared patient groups receiving Isoniazid with and without Pyridoxine, monitoring the incidence of peripheral neuropathy and specific Pyridoxine biomarker levels. Trials described the measured incidence of reported peripheral neuropathy cases and reported that Pyridoxine was associated with measurements of neurological biomarkers. Research is ongoing to determine the Pyridoxine dosage explored that can be associated with maximum stability for all identified high-risk subgroups (such as older adults or those with diabetes), as findings were mixed.


Long-Term Studies and Durability of Outcomes

Research has examined the long-term patterns associated with treatment completion using Observational cohort studies to monitor patient health outcomes for multi-year periods. These studies explore the recurrence of tuberculosis infection and the continued stability of neurological health in patients who were given the Pyridoxine component. Long-term effects are not fully established beyond five years post-treatment, and follow-up durations were limited in many of the initial trials for neuropathy incidence.


Evidence in Specific Patient Groups

The research has examined the combination's use in several specific patient groups. Studies evaluated Isoniazid regimens in children and explored Pyridoxine supplementation in high-risk groups with co-existing conditions like diabetes or malnutrition. The findings indicate that Pyridoxine was associated with measured neurological outcomes in these populations. Data for certain groups remain insufficient, and subgroup findings are uncertain due to modest sample sizes.


What Remains Uncertain and Areas for Future Research

Scientific literature highlights areas where certainty remains low. The evidence base notes a limitation in confirming the Pyridoxine dosage explored in the context of neuropathy incidence. Furthermore, data are still emerging regarding the clinical use for patients with drug-resistant forms of tuberculosis, and long-term effects are not fully established regarding both disease recurrence and neurological health. This research highlights what is known — and what is still uncertain.

Frequently Asked Questions (FAQ)

Common questions about TB Vit 6 (FAQ)

Q: Why is TB Vit 6 sometimes used with other tuberculosis medications?

TB Vit 6 contains Isoniazid and Pyridoxine (Vitamin B6). The Isoniazid component is used in combination with other anti-tuberculosis medications for the treatment of active infection and the prevention of drug-resistant bacteria. The Pyridoxine component is specifically included to help prevent or lessen nerve-related side effects, such as peripheral neuropathy, that can be caused by the Isoniazid.

Q: Are there different versions or strengths of TB Vit 6?

Official information indicates that Isoniazid, the primary drug in this product, is available in tablet strengths of 100 mg and 300 mg. The specific formulation and strength are based on the treatment protocol as defined in the official prescribing information.

Q: Are there any long-term health concerns associated with using TB Vit 6?

A significant concern noted in regulatory documents is the risk of hepatitis (severe and potentially fatal liver damage), which can occur even after several months of use. This risk is reported to increase with age. For this reason, official guidelines note that close monitoring is advised during the long course of treatment.

Q: Are there any food or drink restrictions when using TB Vit 6?

Official warnings state that alcohol is generally avoided because its daily consumption is associated with a higher risk of liver damage caused by the medication. Additionally, certain foods high in tyramine (like aged cheese and red wine) and histamine are also advised to be avoided due to the potential for severe reactions.

Q: Is the research on TB Vit 6 use in children extensive?

Official prescribing information includes specific dosing regimens for children, indicating evidence supports its use. The decision for use in younger children is based on a careful assessment of their risk of exposure to the infection.

Q: Is TB Vit 6 a vitamin supplement or a prescription drug?

TB Vit 6 is an FDA-approved antibacterial prescription drug used for the treatment and prevention of tuberculosis. While it contains Vitamin B6 (Pyridoxine), the product as a whole is classified as a prescription medication, not a dietary supplement.

Q: What is the main reason a doctor might prescribe TB Vit 6?

According to official documentation, the primary reason for prescribing this medication is the treatment and prevention of tuberculosis (TB) infection.

Q: How long does it typically take for TB Vit 6 to start working?

Pharmacology studies indicate that peak blood levels of the Isoniazid component are typically reached within one to two hours after taking the tablet. However, the overall therapeutic effect is a long-term process that requires adherence to the full prescribed course.

Q: What are the most commonly reported side effects of TB Vit 6?

The most frequent adverse reactions affect the nervous system (leading to peripheral neuropathy, or numbness/tingling) and the liver (including elevated enzyme levels). Gastrointestinal reactions such as nausea and vomiting are also commonly reported.

Q: Is it normal to feel tired when taking TB Vit 6?

Official warnings state that fatigue and weakness are among the symptoms patients are advised to report to a healthcare professional immediately. These symptoms may suggest the potential onset of liver damage (hepatitis).

Q: Can TB Vit 6 cause stomach upset?

Yes, official adverse reaction lists include common gastrointestinal issues such as nausea, vomiting, and epigastric distress (stomach discomfort).

Q: Can TB Vit 6 affect sleep patterns?

Regulatory documents list potential neurotoxic effects, which may include reactions like toxic psychosis and memory impairment. These are central nervous system effects that could indirectly impact sleep, though sleep disturbance is not explicitly listed as a common side effect.

Q: Does TB Vit 6 interact with common pain relievers like Tylenol (acetaminophen)?

Official drug interaction information reports that concurrent use with acetaminophen has been shown to increase the risk of liver damage (hepatotoxicity).

Q: Can taking TB Vit 6 with a multivitamin cause a problem?

Official adverse reaction reports indicate the drug can affect the body's levels of certain other vitamins, such as Vitamin D and folate. All supplements and medicines may require discussion with a healthcare provider to assess potential interactions.

Q: Is it safe to take TB Vit 6 while pregnant?

The use of the drug during pregnancy is generally described as having a greater benefit than the risk posed by untreated TB infection. Pyridoxine (B6) supplementation is specifically recommended for the pregnant patient during treatment.

Q: What information is available about TB Vit 6 use during breastfeeding?

Official guidance states that the small amount of Isoniazid that is excreted into breast milk is not expected to cause toxicity to the nursing infant, and therefore breastfeeding is not generally discouraged.

Q: Is TB Vit 6 appropriate for elderly patients?

Prescribing information notes that while specific dose adjustments are often not required, the risk of hepatitis increases with age. Therefore, increased caution and monitoring is described as being advised for elderly patients.

Q: Are there specific medical conditions that mean someone cannot use TB Vit 6?

The drug is contraindicated (should not be used) in patients with acute liver disease or a history of severe hepatic injury related to the drug. Caution is described as being advised for those with chronic liver disease, pre-existing peripheral neuropathy, and diabetes.

Q: What happens if a dose of TB Vit 6 is missed?

The prescribing information emphasizes the critical importance of avoiding missed doses throughout the course of treatment. This strict adherence is necessary to ensure the complete clearance of the TB infection and prevent the emergence of drug-resistant bacteria.

Q: What is the function of TB Vit 6 in the body, according to official documents?

The Isoniazid component functions by inhibiting the synthesis of mycolic acids, which are an essential component of the bacterial cell wall of the TB pathogen.

Q: How does the action of TB Vit 6 relate to nerve health?

The drug's primary component, Isoniazid, can cause a deficiency of Pyridoxine (Vitamin B6), which is essential for nerve function. This depletion can lead to peripheral neuropathy (nerve damage), which is why Pyridoxine is included in the combination—to help protect nerve health.

Q: Do studies support the use of TB Vit 6 for reducing side effects of other drugs?

Yes, official documents confirm that the use of the Pyridoxine (Vit B6) component is supported to prevent or lessen the nerve damage (peripheral neuropathy) that is caused by the co-administered Isoniazid component.

Q: What is the scientific evidence for TB Vit 6 being used in preventative care?

The medication is officially indicated in prescribing information not only for treating active disease but also for the preventive therapy of tuberculosis infection in specific high-risk groups.

Q: Can people with kidney problems use TB Vit 6?

Caution and careful monitoring are advised for patients with severe renal dysfunction (kidney issues). Dosage adjustments may be necessary in only the most severe cases of kidney impairment.

Q: What are the official regulatory safety ratings for TB Vit 6?

The Isoniazid component has been classified by the FDA as a Pregnancy Category C medicine. This rating indicates that there are animal studies suggesting risk, but the potential benefit may warrant use in pregnant women despite potential risks.

Q: Does TB Vit 6 have any known mood-related side effects?

Uncommon neurotoxic effects listed in regulatory documents include toxic psychosis and memory impairment. These are central nervous system effects that could be perceived as mood-related changes.

Q: How quickly does TB Vit 6 leave the body?

Pharmacokinetic studies indicate that the elimination half-life of Isoniazid is typically reported as being between one and four hours. The specific rate varies significantly depending on an individual's metabolic speed.

Q: What should a patient do if they notice unusual symptoms while on TB Vit 6?

Patients are advised to immediately report symptoms that may suggest hepatitis, such as unexplained fatigue, weakness, nausea, vomiting, loss of appetite, and dark urine. This is due to the potential for severe liver-related adverse reactions.

Q: Is it possible to have an allergic reaction to TB Vit 6?

Yes, hypersensitivity reactions (including fever and skin eruptions) are listed as potential adverse reactions. Official documents state that a history of a severe allergic reaction to the drug is a contraindication for its use.

Q: Does TB Vit 6 require any special monitoring while being taken?

Patients are advised to be monitored carefully, particularly for signs of liver injury. Official guidelines often recommend periodic checking of serum transaminase levels (liver function tests), especially in high-risk patients.

Q: Are there any known drug-disease interactions for TB Vit 6?

Yes, prescribing information notes interactions with disease states. These include conditions such as acute and chronic liver disease, and conditions that predispose a patient to peripheral neuropathy, like diabetes mellitus.

Q: How is TB Vit 6 officially classified by major health agencies?

The Isoniazid component is officially classified by health agencies as an antibacterial drug, specifically used against Mycobacterium tuberculosis.

Q: What do official sources say about the safety profile of TB Vit 6?

The official safety profile includes a boxed warning for severe and sometimes fatal hepatitis. The most frequent reactions affect the nervous system and the liver, requiring careful monitoring.

Q: Does TB Vit 6 interact with alcohol?

The prescribing information notes that alcohol consumption is generally avoided. The daily ingestion of alcohol is associated with a higher incidence of hepatitis caused by the Isoniazid component.

Q: Can people with liver issues use TB Vit 6?

The medication is contraindicated in patients with acute liver disease. Caution and careful monitoring are advised for those with chronic liver disease.

Q: Why might a patient be asked to stop taking TB Vit 6?

The drug may be discontinued promptly if symptoms or signs suggestive of progressive liver damage (hepatitis) or a severe hypersensitivity reaction are detected. These are conditions that may warrant immediate cessation of the medicine.

Q: What happens if I take more TB Vit 6 than described in the patient leaflet?

Information on overdosage indicates that symptoms may include vomiting, severe dizziness, slurred speech, hallucinations, and seizures. Immediate medical attention may be warranted in such a situation.

Q: Is there research on TB Vit 6's effectiveness in different patient groups?

Yes, regulatory documents often specify effectiveness and appropriate use in different groups, such as those with HIV infection and various age groups (pediatric and geriatric), supported by clinical studies.

Q: Are there official warnings about driving or operating machinery while on TB Vit 6?

Adverse reactions listed include neurotoxic effects such as dizziness, memory impairment, and convulsions. These effects may impair a person's ability to safely perform tasks requiring full mental alertness, such as driving.

Q: What is the difference between TB Vit 6 and other B vitamins?

The product is a combination of an antibacterial drug (Isoniazid) and one specific B vitamin: Pyridoxine, which is Vitamin B6. It is not a general multivitamin and is not intended to replace other B vitamins in a general nutritional context.

Q: Can a patient stop taking TB Vit 6 suddenly?

The prescribing information emphasizes the critical importance of taking the medicine for the full duration of the treatment plan to effectively clear the infection and prevent the emergence of drug-resistant bacteria. The decision for discontinuation is typically managed by a healthcare provider.

Q: What kind of studies have been done on TB Vit 6?

The labels refer to various types of supporting research, including Clinical Studies to determine efficacy (how well the drug works) and Pharmacokinetic studies to understand how the drug is absorbed, metabolized, and eliminated by the body.

Q: Does TB Vit 6 contain any common allergens like gluten or lactose?

The inactive ingredients for the Isoniazid component are often listed in the product description. These commonly include substances such as lactose monohydrate (a form of milk sugar).

How should TB Vit 6 be stored and disposed of?

Storage and Disposal of TB Vit 6

Official regulatory documents define specific environmental and handling requirements for storing TB Vit 6 (Isoniazid and Pyridoxine Hydrochloride tablets).


Storage Conditions

  • Temperature: Store at Controlled Room Temperature, which is typically 20 C to 25 C (68 F to 77 F). Do not freeze the tablets.
  • Protection: The medicine must be protected from light and moisture to maintain product integrity.
  • Container: Keep the medicine in its original container with the lid tightly closed.
  • Safety: Always store TB Vit 6 out of the reach and sight of children.

Disposal Instructions

Unused or expired medication must be safely thrown away by following the official governmental disposal guidelines, such as medication take-back programs. Disposal must be carried out in accordance with local requirements; do not throw the product into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of TB Vit 6 found in:

A-Z Index: